Both in Pharmaceuticals
Regeneron Pharmaceuticals vs Pfizer
Over the past year REGN returned +44.5% and PFE returned +23.8%; their daily moves had a correlation of 0.41.
REGN +44.5% PFE +23.8%Growth of $1, one year, split-adjusted
| Metric | REGN | PFE |
|---|---|---|
| Price | $927.89 | $30.52 |
| Market cap | $95.99B | $173.95B |
| Today | +13.33% | +1.90% |
| 1 month | +26.3% | +8.5% |
| 6 months | +32.3% | +15.9% |
| Year to date | +20.2% | +22.6% |
| 1 year | +42.1% | +25.6% |
| Revenue growth (YoY) | +36.3% | +2.6% |
| Gross margin | 88.8% | 72.8% |
| Net margin | 38.1% | −1.6% |
| P/E (TTM) | 19.9× | 40.2× |
| Price / sales | 5.7× | 2.7× |
| Net cash | $6.59B | -$51.49B |
| Dividend yield | 0.41% | 5.64% |
| Volatility (60d) | 37.0% | 19.8% |
| Short % of float | 2.2% | 2.4% |
| Next earnings | — | Nov 3, 2026 |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).